Filovirus‐Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2) , S421-S429
Abstract
Background. Virus-like particles (VLPs) of Ebola virus (EBOV) and Marburg virus (MARV) produced in human 293T embryonic kidney cells have been shownKeywords
This publication has 38 references indexed in Scilit:
- Analysis of Ebola virus and VLP release using an immunocapture assayJournal of Virological Methods, 2005
- Filovirus-like particles as vaccines and discovery toolsExpert Review of Vaccines, 2005
- Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infectionsVaccine, 2005
- Contribution of Ebola Virus Glycoprotein, Nucleoprotein, and VP24 to Budding of VP40 Virus-Like ParticlesJournal of Virology, 2004
- Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse GeneticsJournal of Virology, 2004
- Ebola virus-like particles protect from lethal Ebola virus infectionProceedings of the National Academy of Sciences, 2003
- Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GPJournal of Virology, 2002
- VP40, the Matrix Protein of Marburg Virus, Is Associated with Membranes of the Late Endosomal CompartmentJournal of Virology, 2002
- Ebola Virus VP40-Induced Particle Formation and Association with the Lipid BilayerJournal of Virology, 2001
- Vesicular Release of Ebola Virus Matrix Protein VP40Virology, 2001